Examkin

Question

Difficulty: MediumGastroenterology and Hepatology

A 60-year-old man with decompensated alcohol-associated cirrhosis is brought to the emergency department by his wife due to worsening confusion, lethargy, and a reversed sleep-wake cycle over the past 3 days. He has a past medical history of chronic obstructive pulmonary disease and heart failure with preserved ejection fraction. One week ago, his physician increased his oral furosemide and spironolactone doses to manage worsening lower extremity edema. He has not had a bowel movement in 3 days.

Vital signs:
Temperature: 37.1°C (98.8°F)
Blood pressure: 105/65 mm Hg
Pulse: 95/min
Respiratory rate: 12/min
Oxygen saturation: 94% on room air

Physical examination reveals scleral icterus, a markedly distended abdomen with shifting dullness, and bilateral 2+ pitting pedal edema. Neurologic examination shows lethargy, disorientation to time and place, and a bilateral flapping tremor of the hands upon wrist extension.

Laboratory results:
Serum sodium: 132 mEq/L
Serum potassium: 2.8 mEq/L
Serum chloride: 92 mEq/L
Serum bicarbonate: 35 mEq/L
Blood urea nitrogen: 42 mg/dL
Serum creatinine: 1.6 mg/dL (baseline 0.9 mg/dL)
Arterial blood gas (room air): pH 7.51, PaCO₂ 48 mm Hg, PaO₂ 70 mm Hg

Diagnostic paracentesis yields clear yellow fluid with a neutrophil count of 120/mm³.

In addition to administering lactulose, which of the following is the most appropriate next step in the management of this patient?

  1. A
    Administration of additional intravenous furosemide
  2. B
    Placement of a nasogastric tube for bowel decompression
  3. Intravenous potassium chloride repletionAnswer
  4. D
    Initiation of intravenous piperacillin-tazobactam
  5. E
    Endotracheal intubation and mechanical ventilation

Answer

Intravenous potassium chloride repletion
The correct intervention is intravenous potassium chloride repletion. The patient has hepatic encephalopathy precipitated by severe hypokalemia and pre-renal azotemia, which is a direct consequence of over-diuresis (recent increase in furosemide and spironolactone). Hypokalemia strongly exacerbates hepatic encephalopathy through two mechanisms: first, it induces an intracellular acidosis in renal tubular cells that stimulates glutaminase, thereby increasing renal ammonia production; second, the accompanying metabolic alkalosis favors the conversion of ammonium (NH4+NH_4^+) to uncharged ammonia (NH3NH_3), which readily crosses the blood-brain barrier. Alongside standard therapies like lactulose, reversing the hypokalemia is the most critical step in managing this patient's encephalopathy.

Step-by-Step Solution

1
Identify the primary clinical syndrome
The patient presents with altered mental status and asterixis in the setting of cirrhosis, which is diagnostic of hepatic encephalopathy.
Recognizing the primary acute condition dictates the search for a specific precipitating cause.
2
Analyze the laboratory data for precipitants
Laboratory results show severe hypokalemia (2.8 mEq/L), metabolic alkalosis (bicarbonate 35 mEq/L), and pre-renal azotemia (BUN 42 mg/dL), likely resulting from recent diuretic dose increases.
Hepatic encephalopathy is frequently triggered by metabolic derangements, infections, or gastrointestinal bleeding. Identifying the specific trigger is necessary for definitive management.
3
Evaluate the acid-base status and respiratory compensation
The expected PaCO₂ for a bicarbonate of 35 mEq/L is calculated as 0.7×(35−24)+40=47.70.7 \times (35 - 24) + 40 = 47.7 mm Hg. The measured PaCO₂ of 48 mm Hg indicates appropriate and expected respiratory compensation.
This calculation rules out a primary respiratory acidosis (e.g., from a COPD exacerbation or respiratory failure) and confirms the hypercapnia is purely compensatory.
4
Determine the most appropriate targeted intervention
In addition to lactulose to clear enteric ammonia, the patient requires immediate intravenous potassium chloride repletion.
Hypokalemia directly increases renal ammonia production and shifts ammonium (NH4+NH_4^+) to absorbable ammonia (NH3NH_3), aggressively driving the encephalopathy.

Key Concept

Precipitants and management of hepatic encephalopathy
Rate this question

Topics

Gastroenterology and Hepatology

More questions from this topic